The company is moving from a 900-square-foot space to a 2,800-square-foot space. DiFUSION is working to commercialize its first product line, Xiphos. Its second product, CleanFUZE, is pending FDA approval and could go into clinical studies next year.
CleanFUZE is a spinal implant that time-releases antimicrobial silver ions to prevent infections.
Read the report on DiFusion Technologies.
Related Articles on Orthopedic Device Companies:
14 New Orthopedic and Spine Device Company Financial Reports
Orthopedic Device Company Nomcomed Plans $2.78M Expansion to Indiana Facility
Orthopedic Device Company CEOs Expect Market Growth in 2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
